The guidelines were developed ostensibly to assist institutional officials and members of institutional inquiry and investigation committees as they handle allegations of research misconduct related to human patient studies and clinical trials. For the guidelines to be beneficial, they should provide clear guidance on the types of evidence, appropriate procedures, and various authorities necessary for the institution to respond effectively to alleged misconduct.